With Cancer, Celebrate Hope

Article

As any cancer survivor is aware, the blossom of hope can be a fragile flower.

Celebrate (v.) from Latin celebrates: "much-frequented; kept solemn”

I recently had the privilege of speaking to 300 survivors, family members and professional care givers at the Michigan Comprehensive Cancer Center’s, Survivors Day Celebration.

The event was inspiring, moving and heart-wrenching. The festive atmosphere was rich with flower arrangements, balloons, prizes and t-shirts. Poignantly, attendees were given buttons to wear where they could write in the number of years they have logged in as a survivor. Seeing numbers like, five,seven, 17 and 30 gave instant weight to the theme of the event which was, Hope Blooms.

As any cancer survivor is aware, the blossom of hope can be a fragile flower. This was best pointed out to me when a woman in her 70s came to the table that my wife and I were sitting at to tell us that she was a survivor of breast cancer. Mid-way through my heart-felt congratulations, she stopped me with, “But wait.” I knew whatever was coming next was going to hit right at core of what being a cancer survivor really means. In a worried tone, the woman went on to say that she had recently been diagnosed with a form of liver cancer and that her treatment options were limited and one was “a clinical trial.” She was clearly shaken up by the return of cancer and anxious about what course of treatment to take, if any.

What I was not prepared for was her direct question, “What should I do?” My mind reeled between the therapist in my head, which knows never to give direct advice, and the emotional need to carry the hope banner. Struggling to contain the anger I feel anytime I hear that someone who has already been through the treatment ringer has to face it again, I went with an empathic response, while trying hard to not give away the fact the not knowing what I will do should my cancer resurface keeps me up at nights. My response was, “I can’t tell you what you should do, because I don’t have the answer. I do know that if it was me, I would do what I did when I was diagnosed which was seek out the best medical opinions I could find, get a second and third opinion, and involve everyone whom I love in the decision.”

I would be lying if I said the woman left relieved to hear such “wisdom.” What’s truer is that the fear was still on her face and she politely thanked me for my time. Not knowing if that woman will have the opportunity to attend next year’s celebration, and add one more year to her survivor button, could haunt a person for a long time. In my case, the festive air of the event, the smiles of survivors and their family members, even as they told stories of profound challenges, kept hope blooming. I kept reminding myself of the message that I ended with during my keynote moment. “Despite cancer’s attempts to convince us otherwise, we are each, in our true essence, perennial—meaning enduring and everlasting.”

I’m determined that my own wildflower of hope will ultimately be measured not by its roots, stem or pedals, but its fragrance—the soul and spirit that outlives all illness. I hold firmly to the belief that one survivor implies all survivors, and our time is not measured by years, but the natural rhythm of the unending cycle of life. That is something to truly celebrate.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content